177 related articles for article (PubMed ID: 12356318)
1. Lipid II induces a transmembrane orientation of the pore-forming peptide lantibiotic nisin.
van Heusden HE; de Kruijff B; Breukink E
Biochemistry; 2002 Oct; 41(40):12171-8. PubMed ID: 12356318
[TBL] [Abstract][Full Text] [Related]
2. The orientation of nisin in membranes.
Breukink E; van Kraaij C; van Dalen A; Demel RA; Siezen RJ; de Kruijff B; Kuipers OP
Biochemistry; 1998 Jun; 37(22):8153-62. PubMed ID: 9609711
[TBL] [Abstract][Full Text] [Related]
3. Assembly and stability of nisin-lipid II pores.
Hasper HE; de Kruijff B; Breukink E
Biochemistry; 2004 Sep; 43(36):11567-75. PubMed ID: 15350143
[TBL] [Abstract][Full Text] [Related]
4. The role of lipid II in membrane binding of and pore formation by nisin analyzed by two combined biosensor techniques.
Christ K; Wiedemann I; Bakowsky U; Sahl HG; Bendas G
Biochim Biophys Acta; 2007 Mar; 1768(3):694-704. PubMed ID: 17254547
[TBL] [Abstract][Full Text] [Related]
5. Mapping the targeted membrane pore formation mechanism by solution NMR: the nisin Z and lipid II interaction in SDS micelles.
Hsu ST; Breukink E; de Kruijff B; Kaptein R; Bonvin AM; van Nuland NA
Biochemistry; 2002 Jun; 41(24):7670-6. PubMed ID: 12056898
[TBL] [Abstract][Full Text] [Related]
6. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
Wiedemann I; Breukink E; van Kraaij C; Kuipers OP; Bierbaum G; de Kruijff B; Sahl HG
J Biol Chem; 2001 Jan; 276(3):1772-9. PubMed ID: 11038353
[TBL] [Abstract][Full Text] [Related]
7. Lantibiotic immunity: inhibition of nisin mediated pore formation by NisI.
AlKhatib Z; Lagedroste M; Fey I; Kleinschrodt D; Abts A; Smits SH
PLoS One; 2014; 9(7):e102246. PubMed ID: 25014359
[TBL] [Abstract][Full Text] [Related]
8. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
[TBL] [Abstract][Full Text] [Related]
9. New Insights into Nisin's Antibacterial Mechanism Revealed by Binding Studies with Synthetic Lipid II Analogues.
't Hart P; Oppedijk SF; Breukink E; Martin NI
Biochemistry; 2016 Jan; 55(1):232-7. PubMed ID: 26653142
[TBL] [Abstract][Full Text] [Related]
10. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
[TBL] [Abstract][Full Text] [Related]
11. Interaction of the lantibiotic nisin with membranes revealed by fluorescence quenching of an introduced tryptophan.
Martin I; Ruysschaert JM; Sanders D; Giffard CJ
Eur J Biochem; 1996 Jul; 239(1):156-64. PubMed ID: 8706701
[TBL] [Abstract][Full Text] [Related]
12. Elucidation of the antimicrobial mechanism of mutacin 1140.
Smith L; Hasper H; Breukink E; Novak J; Cerkasov J; Hillman JD; Wilson-Stanford S; Orugunty RS
Biochemistry; 2008 Mar; 47(10):3308-14. PubMed ID: 18266322
[TBL] [Abstract][Full Text] [Related]
13. Docking and molecular dynamics simulations of the ternary complex nisin2:lipid II.
Mulholland S; Turpin ER; Bonev BB; Hirst JD
Sci Rep; 2016 Feb; 6():21185. PubMed ID: 26888784
[TBL] [Abstract][Full Text] [Related]
14. Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study.
Wiedemann I; Benz R; Sahl HG
J Bacteriol; 2004 May; 186(10):3259-61. PubMed ID: 15126490
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin.
Gut IM; Blanke SR; van der Donk WA
ACS Chem Biol; 2011 Jul; 6(7):744-52. PubMed ID: 21517116
[TBL] [Abstract][Full Text] [Related]
16. Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5.
Paiva AD; Breukink E; Mantovani HC
Antimicrob Agents Chemother; 2011 Nov; 55(11):5284-93. PubMed ID: 21876041
[TBL] [Abstract][Full Text] [Related]
17. Interaction with lipid II induces conformational changes in bovicin HC5 structure.
Paiva AD; Irving N; Breukink E; Mantovani HC
Antimicrob Agents Chemother; 2012 Sep; 56(9):4586-93. PubMed ID: 22687503
[TBL] [Abstract][Full Text] [Related]
18. Aggregates of nisin with various bactoprenol-containing cell wall precursors differ in size and membrane permeation capacity.
Scherer K; Wiedemann I; Ciobanasu C; Sahl HG; Kubitscheck U
Biochim Biophys Acta; 2013 Nov; 1828(11):2628-36. PubMed ID: 23872123
[TBL] [Abstract][Full Text] [Related]
19. Environmental and dynamic effects explain how nisin captures membrane-bound lipid II.
Panina I; Krylov N; Nolde D; Efremov R; Chugunov A
Sci Rep; 2020 Jun; 10(1):8821. PubMed ID: 32483218
[TBL] [Abstract][Full Text] [Related]
20. Membrane lipids determine the antibiotic activity of the lantibiotic gallidermin.
Christ K; Al-Kaddah S; Wiedemann I; Rattay B; Sahl HG; Bendas G
J Membr Biol; 2008; 226(1-3):9-16. PubMed ID: 19009315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
